PRF Technologies (PRFX) Net Cash Flow (QoQ) (2020 - 2024)
PRF Technologies (PRFX) Net Cash Flow (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 195.22% |
| Mar 31, 2024 | -889.34% |
| Dec 31, 2023 | -80.57% |
| Sep 30, 2023 | 180.39% |
| Jun 30, 2023 | -174.18% |
| Mar 31, 2023 | 242.54% |
| Dec 31, 2022 | 58.98% |
| Sep 30, 2022 | -335.14% |
| Jun 30, 2022 | -43.59% |
| Mar 31, 2022 | 99.99% |
| Dec 31, 2021 | -200.01% |
| Sep 30, 2021 | 749,756.22% |
| Jun 30, 2021 | -143.58% |
| Mar 31, 2021 | 285.22% |
| Dec 31, 2020 | -111.78% |
| Sep 30, 2020 | 17,273.00% |
| Jun 30, 2020 | 53.49% |